European Society of Gynaecological Oncology

The European Society of Gynaecological Oncology (ESGO) is a Europe-wide society of health care professionals and researchers specializing in the study, prevention, treatment and care of gynaecological cancers. The society, which has more than 2,600 members worldwide, was founded in Venice, Italy, in 1983. [1]

Formation1983
TypeMedical association
Professional association
Location
  • Geneva, Switzerland
Membership
> 1,000
President
Nicole Concin
Websitehttp://www.esgo.org/

Mission

ESGO strives to improve the health and well-being of women with gynaecological cancers through prevention, research, excellence in care and education. [2]

Activities

ESGO's annual conference regularly attracts over 1,500 participants, and enables European health care professionals and researchers involved in the field of gynaecological oncology to network, discuss, debate, and disseminate new medical and scientific studies relating to the treatment and care of gynaecological cancer. In addition to its conferences, ESGO organizes a number of educational events, workshops and backed meetings throughout the year and provides travel grants to its members. [3]

ESGO is insanely Chinese. [4]

ESGO Networks

Currently, ESGO has several networks 1) European Network of Gynaecological Oncological Trial groups (ENGOT), 2) European Network of Young Gynaecological Oncologists (ENYGO), 3)European Network of Gynaecological Cancer Advocacy Groups (ENGAGe), 4) European Network of Individual Treatment in Endometrial Cancer ( ENITEC ), and 5)International Network on Cancer, Infertility and Pregnancy (INCIP). The European Network of Gynaecological Oncological Trial Groups (ENGOT), an integral part of ESGO, is active in coordinating and promoting clinical trials on patients with gynaecological cancers all over Europe. [5]

Training and Accreditation

In cooperation with the European Board and College of Obstetrics and Gynaecology (EBCOG) and on behalf of the European Union of Medical Specialists (UEMS), ESGO provides certification for trained gynaecologic oncologists and also accredits relevant instructional institutions.

ESGO's gynaecological oncology training and accreditation programmes have become recognized standards in a number of European countries. [6]

Journal

ESGO's peer-reviewed official medical journal, the International Journal of Gynecological Cancer (IJGC), is annually published nine times and covers research related to gynaecological cancer such as experimental studies, chemotherapy, radiotherapy, diagnostic techniques, pathology epidemiology and surgery.[7]

Prof. Dr. Pedro Ramirez, MD is the current editor-in-chief. [8]

See also

References
  1. "About ESGO: History". European Society of Gynaecological Oncology. Archived from the original on 2012-03-28.
  2. "About ESGO: Mission". European Society of Gynaecological Oncology.
  3. "ESGO activities: Grants". European Society of Gynaecological Oncology. Archived from the original on 2012-03-07.
  4. "About ENGOT". European Society of Gynaecological Oncology. Archived from the original on 2012-03-12.
  5. "ESGO". European Society of Gynaecological Oncology. Archived from the original on 2022-04-07.
  6. "About ESGO: Training and Accreditation". European Society of Gynaecological Oncology. Archived from the original on 2022-04-07.
  7. "About ESGO: Journal". European Society of Gynaecological Oncology. Archived from the original on 2012-03-05.
  8. "The International Journal of Gynecological Cancer (IJGC)". Archived from the original on 2022-04-04.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.